James Wolf Ups Stake In Enzo, May Seek Board Seat
Fintel reports that James Wolf has filed a 13D/A form with the SEC disclosing ownership of 4,942,400 shares of Enzo Biochem Inc (NYSE:ENZ). This represents 10.14% of the company. In is previous filing dated November 23, 2022 Wolf reported 4,168,500 shares and 8.56% of the company, an increase in shares of 18.57% and an increase in total ownership of 1.58% (calculated as current – previous percent ownership. Wolf said in the filing he may nominate himself for election as a director of the Company at the next annual meeting of shareholders if he is not nominated or approved by the Board of Direc...